Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(14%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
2
29%
Ph phase_4
1
14%
Ph not_applicable
4
57%

Phase Distribution

0

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
2(28.6%)
Phase 4Post-market surveillance
1(14.3%)
N/ANon-phased studies
4(57.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(2)
Completed(2)
Other(3)

Detailed Status

unknown3
Completed2
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (28.6%)
Phase 41 (14.3%)
N/A4 (57.1%)

Trials by Status

unknown343%
recruiting114%
not_yet_recruiting114%
completed229%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
DEVICE
Total Trials
7